ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Litton’s New Fredrick Award Could Total Around $30 Million

July 30, 1976

Taxol Issue Prompts Questions Forom Reader

July 26, 1991

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994